Lotus Pharmaceuticals, Inc. Stock Other OTC
Equities
LTUS
US5457152032
Pharmaceuticals
Financials (USD)
Sales 2009 | 57.82M | Sales 2010 | 72.7M | Capitalization | 69.15M |
---|---|---|---|---|---|
Net income 2009 | 16M | Net income 2010 | 14M | EV / Sales 2009 | 1.02 x |
Net Debt 2009 | 5.29 | Net Debt 2010 | 4.65 | EV / Sales 2010 | 0.95 x |
P/E ratio 2009 |
3.88
x | P/E ratio 2010 |
4.84
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.78B | |
+20.44% | 21.89B | |
+10.86% | 14.45B | |
+13.07% | 13.63B | |
+37.46% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.06B |